GENE THERAPY - EVOLVED Trademark

Trademark Overview

On Monday, February 8, 2021, a trademark application was filed for GENE THERAPY - EVOLVED with the United States Patent and Trademark Office. The USPTO has given the GENE THERAPY - EVOLVED trademark a serial number of 90517606. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, June 4, 2024. This trademark is owned by Saliogen Therapeutics, Inc.. The GENE THERAPY - EVOLVED trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific and laboratory research services in the fields of gene, genome and cellular editing, modification, engineering and regulation for use in developing human and veterinary pharmaceutical and biological preparations; custom design and development of engineered cell lines for others for use in scientific research, and drug discovery and development
gene therapy - evolved

General Information

Serial Number90517606
Word MarkGENE THERAPY - EVOLVED
Filing DateMonday, February 8, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateTuesday, June 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 19, 2021

Trademark Statements

NOT AVAILABLE"GENE THERAPY"
Goods and ServicesScientific and laboratory research services in the fields of gene, genome and cellular editing, modification, engineering and regulation for use in developing human and veterinary pharmaceutical and biological preparations; custom design and development of engineered cell lines for others for use in scientific research, and drug discovery and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, May 12, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSaliogen Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NameSaliogen Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBurlington, MA 01803

Trademark Events

Event DateEvent Description
Thursday, February 11, 2021NEW APPLICATION ENTERED
Wednesday, May 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 1, 2021ASSIGNED TO EXAMINER
Thursday, September 9, 2021EXAMINERS AMENDMENT -WRITTEN
Thursday, September 9, 2021EXAMINERS AMENDMENT E-MAILED
Thursday, September 9, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, September 9, 2021EXAMINER'S AMENDMENT ENTERED
Thursday, September 9, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 29, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 19, 2021PUBLISHED FOR OPPOSITION
Tuesday, October 19, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 14, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, May 26, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, May 26, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 26, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 9, 2022SOU TEAS EXTENSION RECEIVED
Thursday, June 9, 2022SOU EXTENSION 1 FILED
Thursday, June 9, 2022SOU EXTENSION 1 GRANTED
Saturday, June 11, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 12, 2022SOU TEAS EXTENSION RECEIVED
Monday, December 12, 2022SOU EXTENSION 2 FILED
Monday, December 12, 2022SOU EXTENSION 2 GRANTED
Wednesday, December 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, April 15, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, April 15, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, April 15, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 13, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, June 13, 2023SOU EXTENSION 3 FILED
Tuesday, June 13, 2023SOU EXTENSION 3 GRANTED
Thursday, June 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 4, 2023SOU EXTENSION 4 FILED
Monday, December 4, 2023SOU EXTENSION 4 GRANTED
Wednesday, December 6, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 28, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, February 28, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 28, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 4, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, June 4, 2024SOU EXTENSION 5 GRANTED
Tuesday, June 4, 2024SOU EXTENSION 5 FILED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

evolved therapy gene development research scientific design custom biological preparations cell drug discovery